Interview: Peter Meinshausen – Regional President Evonik Southeast Asia, Australia & New Zealand; Dr. Stefan Randl – VP Sales & Services Asia, Evonik Healthcare, Singapore

69bebcb6cef13b7e66203f35e696d625c86638db26dd13c60fpimgpsh_fullsize_distr7513eb660112b78c1285e97039abfe47a1aef03f546198a4b4pimgpsh_fullsize_distrWhat role has Southeast Asia played within Evonik’s global business since you became regional president? Peter Meinshausen (PM): Considering Southeast Asia to consist of the ASEAN countries, we have seen attractive, steady, and solid growth across the region since I became the regional president of Evonik Southeast Asia, Australia and New Zealand (SEAANZ) seven years ago. With more than 600 million consumers in a comparatively stable economic and political environment, SEAANZ is certainly one of the regions we see the most dynamic growth opportunities in.
"Evonik organizes its business around three global trends: Health & Nutrition, Resource Efficiency and Globalization. For healthcare and nutrition specifically, we work to provide solutions that enable people to stay healthy."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report